Previous close | 5.90 |
Open | 5.90 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 20.00 |
Expiry date | 2024-10-18 |
Day's range | 5.90 - 5.90 |
Contract range | N/A |
Volume | |
Open interest | 84 |
While the top- and bottom-line numbers for Deciphera Pharmaceuticals (DCPH) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Deciphera Pharmaceuticals (DCPH) delivered earnings and revenue surprises of 5.45% and 2.15%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine are included in this Analyst Blog.